Interpretable Machine Learning Models to Predict the Resistance of Breast Cancer Patients to Doxorubicin from Their microRNA Profiles

Doxorubicin is a common treatment for breast cancer. However, not all patients respond to this drug, which sometimes causes life‐threatening side effects. Accurately anticipating doxorubicin‐resistant patients would therefore permit to spare them this risk while considering alternative treatments wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogunleye, Adeolu Z., Piyawajanusorn, Chayanit, Gonçalves, Anthony, Ghislat, Ghita, Ballester, Pedro J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403644/
https://www.ncbi.nlm.nih.gov/pubmed/35785523
http://dx.doi.org/10.1002/advs.202201501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403644/
https://www.ncbi.nlm.nih.gov/pubmed/35785523
http://dx.doi.org/10.1002/advs.202201501

Ejemplares similares